ARCA BIOPHARMA ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Posted on November 14, 2018 by ARCA IT - Press Release, Uncategorized ABIO - 3Q18 Financial Results and Business Update - FINAL
GENETIC-AF PHASE 2B CLINICAL TRIAL ATRIAL FIBRILLATION BURDEN (AFB) RESULTS PRESENTED AT AMERICAN HEART ASSOCIATION 2018 SCIENTIFIC SESSIONS Posted on November 12, 2018 by ARCA IT - Press Release, Uncategorized AHA 2018 - GENETIC-AF AFB Poster Presentation - FINAL
GENETIC-AF Atrial Fibrillation Burden Results – AHA 2018 Posted on November 11, 2018 by ARCA IT - Uncategorized GAF AFB poster for AHA 11118
ARCA BIOPHARMA ANNOUNCES PHASE 2B GENETIC-AF ATRIAL FIBRILLATION BURDEN (AFB) RESULTS SELECTED FOR PRESENTATION AT AMERICAN HEART ASSOCIATION 2018 SCIENTIFIC SESSIONS Posted on November 5, 2018 by ARCA IT - Press Release, Uncategorized AHA 2018 - GENETIC-AF AFB Poster Presentation Announcement - FINAL